This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Symtuza
  • /
  • Study to Evaluate Efficacy of Darunavir/Cobicistat...
Clinical trial

Study to Evaluate Efficacy of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1

Read time: 3 mins
Last updated:30th Mar 2015
Identifier: NCT02269917
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest